Management of febrile neutropenia in a breast cancer patient with SARS-CoV-2 infection during dose-dense adjuvant chemotherapy

Joanna Terebińska, Robert Wojciechowski, Filip Zieliński, Anna Skrzypczyk-Ostaszewicz, Arkadiusz Zegadło, Emil Lisiak, Artur Maliborski, Renata Duchnowska

Vol 19, No 2 (2023)

Clinical vignette

Diagnostic and therapeutic management of cancer patients with pain: recommendations of the Expert Group of the Polish Association for Palliative Care, Polish Association for the Study of Pain, and Polish Association of Clinical Oncology

Wojciech Leppert, Jerzy Wordliczek, Małgorzata Malec-Milewska, Magdalena Kocot-Kępska, Jarosław Woroń, Renata Zajączkowska, Jan Dobrogowski, Maciej Krzakowski, Małgorzata Krajnik

Vol 20, No 2 (2024)

Guidelines / Expert consensus

Recent advances in the treatment of triple-negative breast cancer

Katarzyna Pogoda, Agnieszka Jagiełło-Gruszfeld, Michał Kunkiel, Anna Niwińska, Zbigniew Nowecki

Vol 19, No 6 (2023)

Review paper

IgG4-related disease presenting with cholangitis mimicking cholangiocarcinoma: a case report with a literature review

Mohsenreza Mansoorian, Seyyed Amir Yasin Ahmadi, Shahriar Sabouri

Vol 18, No 5 (2022)

Case report

The impact of yoga practice on cortisol levels in breast cancer patients—a comprehensive review

Aleksandra W. Bratborska, Igor Piotrowski

Online first

Review paper

Uptake of screening mammogram in West Central Illinois during the COVID-19 pandemic: lessons learned

John Owoade Agboola, Oluwasola Stephen Ayosanmi, Oluwatobi Mogbojuri, Maureen Bezold

Vol 18, No 4 (2022)

Research paper

SARS-CoV-2 recurrent infections in a patient with metastatic colon cancer during chemotherapy

Filip Zieliński, Robert Wojciechowski, Joanna Terebińska, Anna Skrzypczyk-Ostaszewicz, Szymon Tomaszewski, Artur Maliborski, Katarzyna Sklinda, Hanna Cyngot, Wojciech Solarek, Magdalena Dobosz-Foligowska, Renata Duchnowska

Vol 19, No 5 (2023)

Clinical vignette

Trastuzumab deruxtecan in the treatment of adult patients with HER2-positive breast cancer

Joanna Kufel-Grabowska

Vol 19, No 5 (2023)

Review paper

Comprehensive geriatric assessment and clinical outcomes of frail older adults with diffuse large B-cell lymphoma: a meta-analysis

Teodoro J. Oscanoa, Xavier Vidal, Brady E. Beltran, Roman Romero-Ortuno

Vol 19, No 6 (2023)

Review paper

Bisphosphonate treatment as a safe choice for treating lung metastases of recurrent giant cell tumor of bone

Hans Kristian Nugraha, Putu Bihan Surya Kinanta, I Gede Eka Wiratnaya

Vol 19, No 3 (2023)

Case report

Vinorelbine plus platinum compared to vinorelbine plus capecitabine in treatment of patients with metastatic triple negative breast cancer previously treated with anthracycline and taxane: a prospective randomized study

Heba Mohamed El-Zawahry, Ayman Abd Al-Samie Gaber, Amany Abd-Elhameed Abou-Bakr, Marwa Nabil Abd-Elhafez, Ahmed Mohamed El-Debawy

Vol 20, No 1 (2024)

Research paper

Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and systemic immune-inflammation index as clinical predictive and prognostic markers in patients with advanced pancreatic cancer receiving gemcitabine monotherapy

Ireneusz Raczyński, Agnieszka Siedlaczek, Joanna Streb, Patryk Zając, Bogumiła Czartoryska-Arłukowicz, Aleksandra Chruściana-Bołtuć, Małgorzata Talerczyk, Katarzyna Wierzbicka, Weronika Radecka, Michał Jurczyk, Barbara Radecka

Online first

Research paper

Commentary to Targeted therapy for advanced cutaneous melanoma

Piotr Rutkowski, Katarzyna Kozak

Vol 18, No 3 (2022)

Commentary

Nivolumab in the treatment of thoracic cancer — new possibilities

Magdalena Knetki-Wróblewska, Kamila Wojas-Krawczyk

Vol 19, No 4 (2023)

Review paper

Patterns of multiple primaries in fortyfour cancer patients: a single-center clinical experience

Mehmet Esat Duymus, Tolga Koseci, Mehmet Serindere, Meral Ceylan, Abdullah Bulgurcu, Ozlem Ipci, Cemile Karadeniz, Yusuf Murat Bag, Dilsa Mizrak Kaya

Vol 19, No 1 (2023)

Research paper

Commentary to Effect of ribociclib plus fulvestrant on overall survival in the treatment of advanced breast cancer — updated MONALEESA-3 results

Barbara Radecka

Vol 18, No 3 (2022)

Commentary

Management of melanoma central nervous system metastases

Piotr Rutkowski, Dorota Kiprian, Tomasz Świtaj, Radosław Michalik, Mateusz Spałek, Katarzyna Kozak, Tomasz Mandat, Bożena Cybulska-Stopa, Monika Dudzisz-Śledź

Vol 20, No 3 (2024)

Guidelines / Expert consensus

Systemic treatment in triple-negative breast cancer patients — standard and novel approaches

Sylwia Dębska-Szmich, Piotr Potemski

Online first

Review paper

Non-drug related costs of treatment with pertuzumab and trastuzumab in HER2-positive breast cancer patients in Poland

Michał Seweryn, Tomasz Banaś, Joanna Augustyńska, Agnieszka Leszczyńska, Paweł M. Potocki

Vol 20, No 3 (2024)

Research paper

Double hit — bispecific antibodies in cancer therapy

Alicja Bogdanowicz, Kamila Wojas-Krawczyk, Natalia Krzyżanowska, Paweł Krawczyk

Online first

Review paper

Serous cystadenocarcinoma of the pancreas with synchronous breast cancer

Martyna Ziemińska, Aldona Ząber, Andrzej Mazurek, Bartłomiej Grala, Renata Duchnowska

Vol 19, No 6 (2023)

Clinical vignette

Is the biology of breast cancer different in patients ≥ 80 years old?

Joanna Hudała-Klecha, Patryk Zając, Agnieszka Siedlaczek, Barbara Radecka

Vol 19, No 4 (2023)

Research paper

Systemic treatment of patients with advanced pancreatic cancer — is there still a place for gemcitabine in the first-line setting? Experience of Polish oncology centers

Ireneusz Raczyński, Patryk Zając, Joanna Streb, Bogumiła Czartoryska-Arłukowicz, Aleksandra Chruściana-Bołtuć, Małgorzata Talerczyk, Katarzyna Wierzbicka, Agnieszka Siedlaczek, Weronika Radecka, Michał Jurczyk, Barbara Radecka

Vol 20, No 3 (2024)

Research paper

Spectacular clinical benefit achieved by multidisciplinary management of a kidney cancer patient

Adam Fałkowski, Aleksandra Żołnierek, Jakub Żołnierek

Vol 20, No 2 (2024)

Case report

Commentary on Trastuzumab deruxtecan in the treatment of adult patients with HER-positive breast cancer

Maciej Krzakowski

Vol 19, No 5 (2023)

Commentary